Anish Patel - Apr 11, 2024 Form 4 Insider Report for Enliven Therapeutics, Inc. (ELVN)

Signature
/s/ Ben Hohl, by power of attorney
Stock symbol
ELVN
Transactions as of
Apr 11, 2024
Transactions value $
-$401,139
Form type
4
Date filed
4/15/2024, 07:06 PM
Previous filing
Apr 10, 2024
Next filing
May 8, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ELVN Common Stock Options Exercise $37K +14.9K +573.85% $2.48 17.5K Apr 11, 2024 Direct F1
transaction ELVN Common Stock Sale -$438K -17.5K -100% $25.03 0 Apr 11, 2024 Direct F1, F2
holding ELVN Common Stock 394K Apr 11, 2024 See footnote F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ELVN Employee Stock Option (right to buy) Options Exercise $0 -14.9K -19.71% $0.00 60.7K Apr 11, 2024 Common Stock 14.9K $2.48 Direct F1, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 29, 2023.
F2 This transaction was executed in multiple trades at prices ranging from $25.00 to $25.52. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
F3 The shares are held by The Patel / Dong Family Trust Dated August 24 2017 for which the Reporting Person serves as trustee.
F4 Shares subject to the option vest in 48 equal monthly installments beginning on August 14, 2021.